0104 GMT - KPJ Healthcare could post sequentially stronger 2Q core net profit, driven by improving patient volume and revenue intensity, alongside margin recovery, RHB IB analyst Eddy Do says in a note. He tips 2Q core net profit at 92 million ringgit, which is 16% stronger on year and 28% higher sequentially. Additional growth could come from newer hospitals moving into profitability as operations mature, he says. KPJ's third center of excellence launch should also support longer-term revenue growth, he adds. RHB maintains a buy rating on KPJ and keeps its target price at 3.77 ringgit. Shares are unchanged at 3.07 ringgit.